ATLANTA BRAVES HOLDINGS IN-C (BATRK)

US0477263026 - Common Stock

38.475  +0.22 (+0.56%)

Fundamental Rating

2

BATRK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. Both the profitability and financial health of BATRK have multiple concerns. BATRK is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year BATRK has reported negative net income.
BATRK had a positive operating cash flow in the past year.
BATRK had negative earnings in each of the past 5 years.
Of the past 5 years BATRK 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of BATRK (-2.86%) is comparable to the rest of the industry.
With a Return On Equity value of -8.39%, BATRK perfoms like the industry average, outperforming 53.03% of the companies in the same industry.
Industry RankSector Rank
ROA -2.86%
ROE -8.39%
ROIC N/A
ROA(3y)-3.79%
ROA(5y)-4.23%
ROE(3y)-13.11%
ROE(5y)-17.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BATRK's Gross Margin of 20.73% is on the low side compared to the rest of the industry. BATRK is outperformed by 80.30% of its industry peers.
In the last couple of years the Gross Margin of BATRK has declined.
BATRK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.61%
GM growth 5Y-25.26%

0

2. Health

2.1 Basic Checks

BATRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BATRK has been increased compared to 1 year ago.
The number of shares outstanding for BATRK has been increased compared to 5 years ago.
The debt/assets ratio for BATRK is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.13, we must say that BATRK is in the distress zone and has some risk of bankruptcy.
BATRK's Altman-Z score of 1.13 is in line compared to the rest of the industry. BATRK outperforms 46.97% of its industry peers.
A Debt/Equity ratio of 1.14 is on the high side and indicates that BATRK has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.14, BATRK is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACCN/A
WACC8.31%

2.3 Liquidity

BATRK has a Current Ratio of 0.70. This is a bad value and indicates that BATRK is not financially healthy enough and could expect problems in meeting its short term obligations.
BATRK has a worse Current ratio (0.70) than 65.15% of its industry peers.
BATRK has a Quick Ratio of 0.70. This is a bad value and indicates that BATRK is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.70, BATRK is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.7

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 74.90% over the past year.
BATRK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.38%.
Measured over the past years, BATRK shows a small growth in Revenue. The Revenue has been growing by 7.71% on average per year.
EPS 1Y (TTM)74.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%260%
Revenue 1Y (TTM)8.38%
Revenue growth 3Y53.25%
Revenue growth 5Y7.71%
Sales Q2Q%493.21%

3.2 Future

Based on estimates for the next years, BATRK will show a very strong growth in Earnings Per Share. The EPS will grow by 80.23% on average per year.
Based on estimates for the next years, BATRK will show a very strong growth in Revenue. The Revenue will grow by 49.31% on average per year.
EPS Next Y-50%
EPS Next 2Y-33.01%
EPS Next 3Y35.02%
EPS Next 5Y80.23%
Revenue Next Year8.13%
Revenue Next 2Y6.67%
Revenue Next 3Y6.74%
Revenue Next 5Y49.31%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BATRK. In the last year negative earnings were reported.
Also next year BATRK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BATRK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 231.15

4.3 Compensation for Growth

BATRK's earnings are expected to grow with 35.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.01%
EPS Next 3Y35.02%

0

5. Dividend

5.1 Amount

No dividends for BATRK!.
Industry RankSector Rank
Dividend Yield N/A

ATLANTA BRAVES HOLDINGS IN-C

NASDAQ:BATRK (1/2/2025, 9:33:16 AM)

38.475

+0.22 (+0.56%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)N/A N/A
Inst Owners76.01%
Inst Owner Change3.35%
Ins Owners1.75%
Ins Owner Change-8.78%
Market Cap2.39B
Analysts84
Price Target56.73 (47.45%)
Short Float %19.23%
Short Ratio6.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.03%
Min EPS beat(2)-55.62%
Max EPS beat(2)39.56%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-3.92%
Max Revenue beat(2)-0.86%
Revenue beat(4)1
Avg Revenue beat(4)-2.45%
Min Revenue beat(4)-11.11%
Max Revenue beat(4)6.09%
Revenue beat(8)1
Avg Revenue beat(8)-14.69%
Revenue beat(12)2
Avg Revenue beat(12)-9.74%
Revenue beat(16)2
Avg Revenue beat(16)-26.09%
PT rev (1m)-1.28%
PT rev (3m)-0.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.63%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)13.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.52
P/FCF N/A
P/OCF 224.41
P/B 4.51
P/tB 10.35
EV/EBITDA 231.15
EPS(TTM)-0.73
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-1.4
FCFYN/A
OCF(TTM)0.17
OCFY0.45%
SpS10.92
BVpS8.54
TBVpS3.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.86%
ROE -8.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.73%
FCFM N/A
ROA(3y)-3.79%
ROA(5y)-4.23%
ROE(3y)-13.11%
ROE(5y)-17.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.61%
GM growth 5Y-25.26%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF N/A
Debt/EBITDA 46.38
Cap/Depr 146.97%
Cap/Sales 14.4%
Interest Coverage N/A
Cash Conversion 81.54%
Profit Quality N/A
Current Ratio 0.7
Quick Ratio 0.7
Altman-Z 1.13
F-Score5
WACC8.31%
ROIC/WACCN/A
Cap/Depr(3y)57.07%
Cap/Depr(5y)86.74%
Cap/Sales(3y)6.67%
Cap/Sales(5y)17.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%260%
EPS Next Y-50%
EPS Next 2Y-33.01%
EPS Next 3Y35.02%
EPS Next 5Y80.23%
Revenue 1Y (TTM)8.38%
Revenue growth 3Y53.25%
Revenue growth 5Y7.71%
Sales Q2Q%493.21%
Revenue Next Year8.13%
Revenue Next 2Y6.67%
Revenue Next 3Y6.74%
Revenue Next 5Y49.31%
EBIT growth 1Y-22.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year790%
EBIT Next 3Y475.04%
EBIT Next 5Y184.57%
FCF growth 1Y-267.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.6%
OCF growth 3YN/A
OCF growth 5Y-56.38%